Trinity Biotech (TRIB) Income towards Parent Company (2009 - 2024)

Trinity Biotech (TRIB) has reported Income towards Parent Company for 16 consecutive years, with -$17.0 million the latest figure, recorded in Q4 2024.

• Quarterly Income towards Parent Company fell 208.16% year-over-year to -$17.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$21.7 million (up 31.69% YoY) and the FY2025 annual result came in at -$37.4 million, down 17.61% from the prior year.
• Income towards Parent Company declined to -$17.0 million in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
• Over the last five years, Income towards Parent Company for TRIB reached as high as $7.3 million in Q3 2020 and fell as low as -$17.0 million in Q4 2024.
• A 5-year average of -$5.1 million and a median of -$5.7 million in 2023 frame the typical range for Income towards Parent Company.
• The largest YoY upside for Income towards Parent Company was 29200.0% in 2020 against a maximum downside of 1152183808.05% in 2020.
• Year by year, Income towards Parent Company stood at -$10.0 million in 2020, then surged by 87.39% to -$1.3 million in 2021, then slumped by 697.47% to -$10.1 million in 2022, then jumped by 45.42% to -$5.5 million in 2023, then slumped by 208.16% to -$17.0 million in 2024.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$17.0 million, -$4.8 million, and -$6.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.